DCT Japan takes clinical trials to the next stage
with innovation and expertise.
Why
DCT Japan
Japan’s DCT* Pioneer.
We are DCT Japan.
DCT Japan was born in 2022, when the Decentralized Clinical Trial era in Japan was still in its infancy, as the nation’s first company dedicated exclusively to this field** . Today, we deliver comprehensive DCT solutions ranging from home nursing and IT platforms to a nationwide satellite site network.
* DCT: Decentralized Clinical Trials
** Although we adopted a new organizational structure in 2026 to strengthen our operations, the core spirit of our mission remains unchanged.
-
A team of 300+ Fully trained nurses supporting nationwide DCT coverage
-
Contracts with 150+ Investigator sites including national university hospitals
-
Trusted by 13/15 Top pharmaceuticals amongst our 30
valued Pharma and Biotech sponsors
Therapeutic Experience
-
Oncology
-
Rare Diseases
-
Infectious Diseases
-
Orthopedics
-
Renal
-
Endocrinology /Metabolic Diseases
-
CNS Disorders
-
Pediatrics
Our Strengths
- Complete DCT technology platform powering our virtual trial solutions
- Mobile nurse coverage of the entirety of Japan
- Network of satellite sites boosting patient reach and recruitment net
- Experienced team of Project Managers providing end-to-end DCT project support
- Consultation services enabled by extensive experience in local regulations
- Expansion and development of infrastructure across Asia allowing DCT in APAC including China, Hong Kong, Taiwan, Singapore, Malaysia, India, South Korea and Thailand
From Planning through to Completion
We offer a complete suite of fully customizable DCT solutions all under one roof.
* Slide the diagram sideways to see in full
Services provided by DCT Japan
* Some services are provided via our affiliated companies.
Planning and Preparation
Consultation
Investigator Site
Structure Establishment
Satellite Site Network
Patient Recruitment
Satellite Site Network
eRecruitment
Informed Consent
eConsent
Visits
(Medical Examinations, Study Procedures and Dosing)
Nursing
Online Medical Examination
Satellite Site Network
IMP Delivery and Logistics
Data Collection
（Subjects to Site）(Site to Sponsor)ePRO
PHR： Device Integration and Connectivity
Online Medical Examination
(Site to Sponsor)eSource
Solution
Digital clinical trial solutions only provided by DCT Japan
Nationwide mobile nurse network and 24/7 service
DCT Japan makes the most of the know-how and human resources of the group medical institution Tetsuyukai, which has experience in more than 20 home nursing clinical trials, and nationwide mobile nurse network to cover all the area for the implementation of home nursing service in the comfort of patient’ home.
Mobile nurses are trained on GCP and the protocol by our well-experienced staff and certified to carry out home visits in compliance with the relevant regulations.
Numerous experiences in indications such as cancer, rare diseases, infectious diseases and orthopaedics
| Rare disease A | Rare disease B | Cancer | Other | |
|---|---|---|---|---|
| Confirmation of the health status of the patient, including concomitant medications | ○ | ○ | ○ | ○ |
| Vital sign | ○ | ○ | ○ | ○ |
| Blood draw | ○ | ○ | ○ | |
| Urine collection | ○ | ○ | ||
| Specimen processing and transport | ○ | ○ | ||
| ECG | ○ | |||
| IMP administration | ○ | ○ | ||
| Explanation of iPad usage to patient | ○ | |||
| Support for telemedicine by investigator | ○ | |||
| Vaccine administration | ○ |
Easier and safer DCT with our digital platform
Telemedicine platform provided by Integrity Healthcare, a group company, is used by more than 4,000 medical institutions nationwide, enabling communication not only between investigators and patients, but also between our Decentralized Trial Assistant (DTA) and mobile nurses to ensure the safety of patients in home clinical trials and improve the quality of work by mobile nurses.
We can help improve enrollment and retention by reducing the burden on patients.
The burden on patients can be reduced by conducting patient recruitment, screening tests, imaging tests at medical institutions close to the patients' homes (Satellite medical institutions).
Through the medical institution network Integrity Healthcare and Tetsuyukai have, DCT Japan can launch satellite medical institutions across the country that contribute to a reduction in the number of trial site and clinical trial cost.
A wide range of consultation support is available, including planning, implementation and follow-up.
Consultation support is provided by in-house experts with extensive experience in DCT and Tetsuyukai doctors, including advice on the design and preliminary research on DCT, selection of devices and introduction of DCT to the trial sites from a medical and clinical point of view, as well as from the point of view of relevant laws and regulations.
Consultation for DCT
- Advice on introducing home nursing clinical trial(Appropriate visit points and activities for home nursing and its feasibility, etc.)
- PMDA consultation support
- Support for trial site selection(based on patient demographics and consideration of introducing satellite medical institutions)
- Research and advice on the introduction of wearable devices and other DCT platform
- Support for the introduction of
DCT to the trial sites - Proposal for comprehensive
DCT structure (eRecruit, Satellite medical institution, home nursing, DCT platform such as telemedicine system, etc.)
Overseas
Expansion
DCT Japan provides DCT services from Japan in cooperation with partners in Asia and other countries, and by becoming a hub, DCT Japan can integrate and improve the quality of work, be point of contact and reduce contractual process, supporting global studies more efficiently.
Information
- 2025.08.08NTT Precision Medicine and DCT Japan Announce Collaboration to Revolutionize Clinical Trial Participant Recruitment
- 2025.06.03DCT Japan to Exhibit at DIA Global Annual Meeting 2025 in Washington DC
- 2025.05.26Clinical Trial Opportunities for More Patients -DCT Japan Expands Partnerships with Medical Institutions in Seven Disease Areas-
Company
- Company Name
- Integrity Healthcare Co., Ltd.
- Establishment
- October 2009
- Management
- President: Shinsuke Muto
Director: Ai Sonoda
General Manager: Hiroyuki Kakigi
- Headquarters
- 4F, +SHIFT TSUKIJI, 3-12-5 Tsukiji, Chuo-ku, Tokyo, JAPAN